Specify a stock or a cryptocurrency in the search bar to get a summary
Vivos Therapeutics Inc
VVOSVivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado. Address: 7921 Southpark Plaza, Littleton, CO, United States, 80120
Analytics
WallStreet Target Price
7.42 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures VVOS
Dividend Analytics VVOS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History VVOS
Stock Valuation VVOS
Financials VVOS
Results | 2019 | Dynamics |